The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback